A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
This study is not yet open for participant recruitment.
Verified January 2013 by GlaxoSmithKline
Information provided by (Responsible Party):
First received: September 22, 2011
Last updated: January 31, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is not yet open for participant recruitment.|
|Estimated Study Completion Date:||July 2013|
|Estimated Primary Completion Date:||July 2013 (Final data collection date for primary outcome measure)|